ART002g1

· Shanghai Jiao Tong University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ART002g1, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Early-phase Study of ART002g1 Injection in HeFH: Safety, Tolerability and Preliminary Efficacy [EARLY_Phase 1]